Latest News of AKYA
Time To Worry? Analysts Just Downgraded Their Akoya Biosciences, Inc. (NASDAQ:AKYA) Outlook
Analysts downgraded revenue forecasts for Akoya Biosciences (NASDAQ:AKYA) signaling a weaker outlook. Revenue estimates were cut sharply, with a 14% projected sales growth in 2025....
AKYA Stock Price | Akoya Biosciences Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
Akoya Biosciences provides spatial biology solutions for research, offering single-cell imaging technology to understand cell interactions in disease. Founded in 2015, the company offers CODEX and Phe...
Akoya Biosciences Inc (AKYA) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ...
The CFO mentioned that major capital expenditures are done for the year, focusing on building a manufacturing center. The CEO discussed exploring strategic alternatives, confident in revenue growth ne...
-
PT Bank Rakyat Indonesia (Persero) Tbk (BKRKF) Q3 2024 Earnings Call Highlights: Strong Profit ...
By Yahoo! Finance | 2 weeks agoPotential for lower credit costs in 2025 if current trends continue, with focus on improving asset quality vintages, capability-building programs for loan officers, and enhancing scoring and underwrit...
-
While institutions own 21% of Akoya Biosciences, Inc. (NASDAQ:AKYA), private equity firms are its largest shareholders with 49% ownership
By Yahoo! Finance | 4 months agoThree investors collectively own 52% of Akoya Biosciences, with private equity firms holding the largest stake at 49%. Institutions and hedge funds also have ownership, influencing the company's direc...